MGMT and neoplasm: Current strategies focus on three main approaches: (1) immunotherapy in conjunction with alkylating agents to target tumors, (2) targeting MGMT to enhance tumor sensitivity to alkylating chemotherapy, and (3) treating patients with nonmethylation of the MGMT promoter.